February 14, 2019 Chengxiang's paper "Antibiotic-Derived Lipid Nanoparticles to Treat Intracellular Staphylococcus aureus" was published by ACS Applied Bio Materials.
January 20, 2019 Chengxiang, Xinfu and Weiyu's paper "Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer" was accepted by Nano Research.
December 14, 2018 Xinfu and Chengxiang's paper "Design, Synthesis, and Evaluation of Anti-CD38 Antibody Drug Conjugate Based on Daratumumab and Maytansinoid" was accepted by Bioorganic & Medicinal Chemistry.
November 19, 2018 Bin's paper "Synthetic oligonucleotides inhibit CRISPR-Cpf1 mediated genome editing" was accepted by Cell Reports.
October 02, 2018 Dr. Dong was selected as the recipient of the 2018 Mary Ann Liebert, Inc. publishers Young Investigator Award and gave an invited talk at the Oligonucleotide Therapeutics Society annual meeting.
September 04, 2018 Xinfu and Weiyu’s paper "Ratiometric Fluorescent Probes for Capturing Endogenous Hypochlorous Acid in the Lungs of Mouse" was published by Chemical Science.
August 30, 2018 Dr. Dong was selected as the recipient of the 2018 Young Innovator in Cellular and Molecular Bioengineering.